Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With <scp>MASLD</scp> and Type 2 Diabetes
GLP-1 RAs are associated with better long-term liver outcomes compared to SGLT2is in patients with MASLD and T2D.
Authors
- Po‐Yu Huang (ORCID: https://orcid.org/0000-0002-8682-1322)
- Chih‐Cheng Lai (ORCID: https://orcid.org/0000-0002-6334-2388)
- Chun‐Hsien Li (ORCID: https://orcid.org/0000-0001-7371-4379)
- Ya‐Wen Tsai (ORCID: https://orcid.org/0000-0003-4630-3923)
- Hsing‐Tao Kuo (ORCID: https://orcid.org/0000-0002-5841-974X)
- Min‐Hsiang Chuang (ORCID: https://orcid.org/0000-0002-8538-4861)
- Chia‐Chih Kuo
Institutions
- National Sun Yat-sen University (TW)
- Chi Mei Medical Center (TW)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1111/apt.18502
- Citations
- 21
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 28.44